^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

MNPR-202

i
Other names: MNPR-202, MNPR 202, camsirubicin analog
Associations
Trials
Company:
Monopar Therap, National University of Singapore
Drug class:
Topoisomerase II inhibitor
Related drugs:
Associations
Trials